| # | Drug | Count |
|---|---|---|
| 0 | EMPAGLIFLOZIN | 1524 |
| 1 | QUETIAPINE | 1215 |
| 2 | METFORMIN | 1180 |
| 3 | METFORMIN ER 500 MG | 1180 |
| 4 | METFORMIN ER 750 MG | 1180 |
| 5 | INSULIN GLARGINE | 704 |
| 6 | CANAGLIFLOZIN | 645 |
| 7 | DAPAGLIFLOZIN | 576 |
| 8 | INSULIN LISPRO | 448 |
| 9 | INSULIN | 255 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 124 | 0.0420 |
| 1 | ERTUGLIFLOZIN AND SITAGLIPTIN | 5 | 0.0417 |
| 2 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 129 | 0.0362 |
| 3 | MAFENIDE ACETATE | 1 | 0.0323 |
| 4 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 98 | 0.0280 |
| 5 | EMPAGLIFLOZIN | 1524 | 0.0219 |
| 6 | CANAGLIFLOZIN | 645 | 0.0216 |
| 7 | EMPAGLIFLOZIN AND LINAGLIPTIN | 39 | 0.0198 |
| 8 | NIRAPARIB TOSYLATE MONOHYDRATE AND ABIRATERONE ACETATE | 1 | 0.0161 |
| 9 | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0156 |
| # | Drug class | Count |
|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2150 |
| 1 | Insulin Analog [EPC] | 1390 |
| 2 | GLP-1 Receptor Agonist [EPC] | 533 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 336 |
| 4 | Atypical Antipsychotic [EPC] | 241 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 234 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 208 |
| 7 | Benzodiazepine [EPC] | 206 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 194 |
| 9 | Corticosteroid [EPC] | 182 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2150 | 0.0197 |
| 1 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 194 | 0.0059 |
| 2 | alpha-Glucosidase Inhibitor [EPC] | 29 | 0.0059 |
| 3 | Aldehyde Dehydrogenase Inhibitor [EPC] | 4 | 0.0035 |
| 4 | Insulin Analog [EPC] | 1390 | 0.0031 |
| 5 | Insulin [EPC] | 140 | 0.0030 |
| 6 | Antihypoglycemic Agent [EPC] | 7 | 0.0016 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 12 | 0.0014 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 28 | 0.0013 |
| 9 | Glinide [EPC] | 11 | 0.0012 |